The Virtual Life Sciences Company and the FDA

Edward John Allera, Chair of Buchanan Ingersoll & Rooney’s Food and Drug Administration & Pharmaceuticals Section, will moderate a panel of executives in the life sciences industry as they explain business and regulatory strategies for meeting new regulatory compliance challenges posed by pharmaceutical, diagnostics, biotech, device and other life sciences companies that outsource critical functions.

Panelists include:

• Luis T. Gutierrez, Jr. – Executive Vice President and Chief Commercial Officer, Aptiv Solutions
• Mark D. Myslinski – Senior Vice President and Chief Commercial Officer, Saladax Biomedical, Inc.
• Robert Radie – President and CEO, Egalet, Ltd
• Dana Smith, CPA, CFF – Partner, EisnerAmper

To register, contact Katie Kozora at katie.kozora@bipc.com.

To learn more, click here.